semaglutide treatment philly Weight loss drugs are big, and has a new contender in the space. Alveus Therapeutics has exited stealth with nearly $160M in Series A funding to develop a next-generation GLP-1 weight-loss Semaglutide at Philly IV Lounge

36 (1), e00285

When these signals fall out of balancewhether due to hormones, genetics, or stressthe hair growth cycle can be disrupted, leading to shedding or thinning

Semaglutide Semaglutide mimics GLP-1 hormone activity and may help support: Appetite control Reduced cravings Longer feelings of fullness Sustainable weight-loss progress Tirzepatide Tirzepatide works through both GLP-1 and GIP receptor pathways and may help support: Appetite regulation Blood sugar balance Metabolic function Additional flexibility for personalized treatment planning Your provider will review your lab work, medical history, goals, and overall health before recommending the most appropriate option

Reniere, M